Prohibits pre-approval or precertification of prenatal ultrasound screenings covered under health benefits plans.
Impact
The implications of A2438 are significant for health care access, particularly for pregnant individuals. By eliminating the requirement for pre-approval or precertification, the bill aims to reduce barriers to timely prenatal care. It is expected to enhance the quality of healthcare for pregnant women, as timely access to ultrasound screenings is often crucial for monitoring fetal development and addressing any health concerns that may arise during pregnancy. The bill applies not only to general health benefit plans but also specifically to those managed by state programs such as the State Health Benefits Program and the School Employees' Health Benefits Program.
Summary
Assembly Bill A2438 seeks to amend health insurance regulations concerning prenatal ultrasound screenings. Specifically, the bill prohibits health insurers and third-party administrators from requiring pre-approval or precertification for prenatal ultrasound procedures that are already covered under health benefit plans. This legislation is introduced to streamline access to necessary prenatal procedures, ensuring that expectant mothers can receive prescribed ultrasounds without bureaucratic delays related to authorizations.
Contention
While the bill is aimed at facilitating healthcare access, potential points of contention may arise from insurance providers concerned about the implications of such changes on cost and regulation. It may lead to discussions about the balance between ensuring necessary health care access and the financial viability of health plans. Stakeholders, including healthcare providers, insurance companies, and patient advocacy groups, may have varying perspectives on how this legislation impacts the healthcare landscape and the potential for increased healthcare costs due to unrestricted access.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Enacts the "health insurance preauthorization disclosure act"; requires health insurance companies to provide participating health care providers with a list of health care treatments and services that require preauthorization from the health insurance company.